4th Alpine Winter Conference on Medicinal and Synthetic Chemistry

 St. Anton, Austria    January 28-February 1, 2024

Keynote Speakers

Universal Organocatalysts for our World

Prof. Benjamin LIST
Prof. Benjamin LIST
MAX PLANCK INSTITUTE, Muelheim an der Ruhr, Germany
Read more

The Discovery of PAXLOVID

Dr Dafydd OWEN
Dr Dafydd OWEN
PFIZER, Cambridge, United States
Read more

Title to be announced

Prof. M. Christina WHITE
Prof. M. Christina WHITE
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN, Urbana, United States

From Underground to Mainstream: Neglected and Novel, Emerging Functional Groups for Drug Discovery

Boron Based Heterocycles and their Application in Drug Discovery

Prof. Bhaskar DAS
Prof. Bhaskar DAS
LONG ISLAND UNIVERSITY, Brooklyn, United States
Read more

“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery

Dr Yoshihiro ISHIHARA
Dr Yoshihiro ISHIHARA
VIVIDION THERAPEUTICS, San Diego, United States
Read more

Deuterium in Drug Design: From Deuterium Switch to De Novo Drug Discovery

Prof. Tracey PIRALI
Prof. Tracey PIRALI
UNIVERSITY OF PIEMONTE ORIENTALE, Novara, Italy
Read more

New Functional Groups for Synthetic and Discovery Chemistry

Prof. Michael WILLIS
Prof. Michael WILLIS
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

Human Dose Prediction in the Discovery Space

Early Human Dose Predictions in Lead Optimization

Dr Johan BYLUND
Dr Johan BYLUND
CTC CLINICAL TRIAL CONSULTANTS AB, Uppsala, Sweden
Read more

Early Human Dose Prediction & Machine Learning Models - Can We Impact Lead Selection?

Dr Gregori GEREBTZOFF
Dr Gregori GEREBTZOFF
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland
Read more

SwiftPK: Development and Implementation of a High Throughput PBPK/PD Framework to Inform Drug Selection in Early Drug Discovery

Dr Andres OLIVARES
Dr Andres OLIVARES
F. HOFFMANN-LA ROCHE, Basel, Switzerland
Read more

Radical Intermediates in Complex Molecule Synthesis

New Methods in Photochemistry and Photocatalysis

Prof. Daniele LEONORI
Prof. Daniele LEONORI
RWTH AACHEN UNIVERSITY, Aachen, Germany
Read more

Recent Developments in Catalysis and Beyond

Prof. Bill MORANDI
Prof. Bill MORANDI
ETH ZÜRICH, Zürich, Switzerland
Read more

Title to be announced

Prof. Cristina NEVADO
Prof. Cristina NEVADO
UNIVERSITY OF ZURICH, Zurich, Switzerland

Natural Product Synthesis Through the Lens of Informatics

Prof. Ryan SHENVI
Prof. Ryan SHENVI
SCRIPPS RESEARCH, La Jolla, United States
Read more

Cryo-EM: Applications for Structure-Based Drug Discovery

Structure-Based Development of Acid Suppressant Targeted for the Gastric Proton Pump

Prof. Kazuhiro ABE
Prof. Kazuhiro ABE
NAGOYA UNIVERSITY, Nagoya, Japan
Read more

Cryo-EM Enables Structure-Based Drug Design for Membrane Protein Targets at BI

Dr Rebecca EBENHOCH
Dr Rebecca EBENHOCH
BOEHRINGER INGELHEIM, Biberach, Germany
Read more

Single Particle CryoEM at 200 kV & Itchy GPRCs

Prof. Jonathan F. FAY
Prof. Jonathan F. FAY
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL, Chapel Hill, United States
Read more

Examples from Structure-Based Drug Discovery at MSD Using cryoEM

Dr Harini KRISHNAMURTHY
Dr Harini KRISHNAMURTHY
MERCK, SHARP & DOHME, Blue Bell, United States
Read more

Recent Developments in Synthetic Methodologies and their Impact

Organic Reactions in Aqueous Medium enabled by Surfactants

Dr Niginia BORLINGHAUS
Dr Niginia BORLINGHAUS
UNIVERSITY OF KONSTANZ, Konstanz, Germany
Read more

Reagents and Catalysts with Translational Potential

Dr Josep CORNELLA COSTA
Dr Josep CORNELLA COSTA
MAX PLANCK INSTITUTE FOR COAL RESEARCH, Mülheim an der Ruhr, Germany
Read more

From Batch to Flow: Advancing Synthetic Organic Chemistry through Technological Innovation

Prof. Timothy NOËL
Prof. Timothy NOËL
UNIVERSITY OF AMSTERDAM, Amsterdam, The Netherlands
Read more

Chemo-Biocatalytic Processes Enabled by a Continuous Flow Set Up

Prof. Francesca PARADISI
Prof. Francesca PARADISI
UNIVERSITY OF BERN, Bern, Switzerland
Read more

Antiviral Drug Discovery

Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections

Dr Helmut BUSCHMANN
Dr Helmut BUSCHMANN
AICURIS ANTI-INFECTIVE CURES GMBH, Wuppertal, Germany
Read more

Targeting Viral RNA Degradation Via Small Molecules As A Novel Antiviral Strategy To Achieve HBV-Cure

Dr Dimitar GOTCHEV
Dr Dimitar GOTCHEV
ARBUTUS BIOPHARMA, Doylestown, United States
Read more

Targeted Protein Degradation as an Approach to Develop Antivirals with Broad-Spectrum Antiviral Activity and High-Barriers to Resistance

Prof. Priscilla YANG
Prof. Priscilla YANG
STANFORD UNIVERSITY, Stanford, United States
Read more

Latest Advances and Approaches in Bioconjugation Drug Discovery

Bicyclic Peptides as a Novel Therapeutic Modality

Dr Mark FRIGERIO
Dr Mark FRIGERIO
BICYCLE THERAPEUTICS, Cambridge, United Kingdom
Read more

Next-Generation Bioconjugates for Intra- and Extracellular Targeting

Prof. Christian HACKENBERGER
Prof. Christian HACKENBERGER
FMP BERLIN, Berlin, Germany
Read more

Creating Next-generation Biotherapeutics Using Novel Chemistry Platform Technologies

Dr Vijaya R. PATTABIRAMAN
Dr Vijaya R. PATTABIRAMAN
BRIGHT PEAK THERAPEUTICS, Basel, Switzerland
Read more

Title to be announced

Dr Alain WAGNER
Dr Alain WAGNER
CNRS/UNIVERSITY OF STRASBOURG, Illkirch, France
Read more